Find participating medical centers and current study status in each of them

    Find participating medical centers

    A clinical trial to look at how well RO7443904 and glofitamab work (when taken together) to treat people with relapsed or refractory Non-Hodgkin’s lymphoma, and how safe the combination is.

    A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma

    • Cancer
    • Non Hodgkin Lymphoma (NHL)
    • Lymphoma